Chair: David Pyott, Chairman & CEO, Allergan, Inc.
Staff Contact: Joseph Damond, Senior Vice President, International Affairs, email@example.com
Subject Matter/Jurisdiction: The committee oversees, in conjunction with other relevant BIO committees, BIO’s international work plan objectives to foster an environment conducive to biotechnology, re-shape the debate on IP and pro-innovation policies, and influence regulatory reform and harmonization discussions in key international markets. The committee’s jurisdiction includes oversight of BIO’s International Affairs Initiative, international organization matters (e.g., WHO, WTO, WIPO, APEC, OECD), international advocacy and education programs, international studies, and coordinating efforts of foreign peer organizations.
David Pyott, Chairman & CEO, Allergan, Inc.
Julie Gerberding, President, Merck Vaccines, Merck & Co, Inc.
Roch Doliveux, Chief Executive Officer and Chairman, UCB SA
Geno Germano, President & General Manager, Specialty Care Business Unit, Pfizer, Inc.
Scott Koenig, President & CEO, MacroGenics, Inc
David Meeker, Executive Vice President, Genzyme Corporation: A Sanofi Company
Arlene Morris, Cheif Executive Officer, Syndax
Francois Nader, President & CEO, NPS Pharmaceuticals, Inc.
Ana Protopapas, President, Millennium: The Takeda Oncology Company
Stephan Tanda, Managing Board Member, DSM Pharmaceutical Products
Bradford Zakes, Chief Executive Officer, Cerevast Therapeutics, Inc.